Contineum Therapeutics, Inc. (CTNM)
Market Open
1 Sep, 19:43
NASDAQ (NGS) NASDAQ (NGS) Primary $
16. 68
+0.44
+2.71%
$
610.97M Market Cap
- P/E Ratio
- Div Yield
147,495 Volume
- Eps
$ 16.24
Previous Close Investors:
Want to track CTNM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Contineum Therapeutics, Inc. (CTNM) Statistics
Valuation metrics
Market Cap 610.97M
Enterprise value 633.3M
Trailing P/E (ttm) -9.86
Forward P/E -
PEG ratio -0.41
Price/Sales (ttm) -
Price/Book (mrq) 2.67
Enterprise Value/Revenue -
Enterprise Value/EBITDA -9.6
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 477.84K
Average volume (90 days) 403.57K
Price summary
52-Week low 8.6
52-Week high 17.51
Beta -
50-Day moving average 15.32
200-Day moving average 13.84
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.23%
Return on equity -0.25%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.54
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.31
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 37.17%
Book value per share (mrq) 6.4
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
